The necessity and utility of abuse liability evaluations in human subjects: the FDA perspective.
Vocci
F J
FJ
Division of Neuropharmacological Drug Products, Office of Drug Evaluation I, Food and Drug Administration, Rockville, Maryland 20857.
D000818:Animals; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D006801:Humans; D013287:Illicit Drugs; D019966:Substance-Related Disorders; D014481:United States; D014486:United States Food and Drug Administration
D013287:Illicit Drugs